SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018484
Filing Date
2024-05-09
Accepted
2024-05-09 16:43:10
Documents
16
Period of Report
2024-05-07
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39598
2 ex16-2.htm EX-16.2 5443
3 ex16-2_001.jpg GRAPHIC 13962
4 ex16-2_002.jpg GRAPHIC 4210
  Complete submission text file 0001493152-24-018484.txt   244082

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bixt-20240507.xsd EX-101.SCH 3027
6 XBRL LABEL FILE bixt-20240507_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bixt-20240507_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3556
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 24931478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)